h1

%0 Journal Article
%A Kiladjian, Jean-Jacques
%A Marin, Francisca Ferrer
%A Al-Ali, Haifa Kathrin
%A Alvarez-Larrán, Alberto
%A Beggiato, Eloise
%A Bieniaszewska, Maria
%A Breccia, Massimo
%A Buxhofer-Ausch, Veronika
%A Cerna, Olga
%A Crisan, Ana-Manuela
%A Danaila, Catalin Doru
%A De Stefano, Valerio
%A Döhner, Konstanze
%A Empson, Victoria
%A Gora-Tybor, Joanna
%A Griesshammer, Martin
%A Grosicki, Sebastian
%A Guglielmelli, Paola
%A García-Gutierrez, Valentin
%A Heidel, Florian H.
%A Illés, Arpád
%A Tomuleasa, Ciprian
%A James, Chloe
%A Koschmieder, Steffen
%A Krauth, Maria-Theresa
%A Krejcy, Kurt
%A Lazaroiu, Mihaela-Cornelia
%A Mayer, Jiri
%A Nagy, Zsolt György
%A Nicolini, Franck-Emmanuel
%A Palandri, Francesca
%A Pappa, Vassiliki
%A Reiter, Andreas Johannes
%A Sacha, Tomasz
%A Schlager, Stefanie
%A Schmidt, Stefan
%A Terpos, Evangelos
%A Unger, Martin
%A Wölfler, Albert
%A Cirici, Blanca Xicoy
%A Klade, Christoph
%T ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
%J Ann Hematol
%V 103
%N 7
%@ 1432-0584
%C Berlin ; Heidelberg ; New York
%I Springer
%M RWTH-CONV-254446
%P 2299-2310
%D 2024
%F PUB:(DE-HGF)16
%9 Journal Article
%U <Go to ISI:>//WOS:001182326400002
%$ pmid:38438627
%R 10.1007/s00277-024-05665-4
%U https://publications.rwth-aachen.de/record/1008089